Mesenchymal stem cells induce an inflammatory response after intravenous infusion

Stem Cells and Development

Volumn 22, Issue 21, 2013, Pages 2825-2835

  Hoogduijn, Martin J ^a   Roemeling Van Rhijn, Marieke ^a   Engela, Anja U ^a   Korevaar, Sander S ^a   Mensah, Fane K F ^a   Franquesa, Marcella ^a   De Bruin, Ron W F ^a   Betjes, Michiel G H ^a   Weimar, Willem ^a   Baan, Carla C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; ENHANCED GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOMODULATION; KIDNEY PARENCHYMA; LIVER; LUNG PARENCHYMA; MACROPHAGE; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPOSE TISSUE; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINES; CYTOKINES; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; INFLAMMATION MEDIATORS; INFUSIONS, INTRAVENOUS; KIDNEY; LIPOPOLYSACCHARIDES; LIVER; LUNG; MACROPHAGES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; TIME FACTORS;

EID: 84885700426     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0193     Document Type: Article

References (39)

1. da Silva Meirelles L, PC Chagastelles and NB Nardi. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204-2213.
2. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
3. Di Nicola M, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, P Matteucci, S Grisanti and AM Gianni. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843.
4. Hoogduijn MJ, MJ Crop, AM Peeters, GJ Van Osch, AH Balk, JN Ijzermans, W Weimar and CC Baan. (2007). Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev 16:597-604.
5. Le Blanc K, F Frassoni, L Ball, F Locatelli, H Roelofs, I Lewis, E Lanino, B Sundberg, ME Bernardo, et al. (2008). Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371:1579-1586.
6. Freedman MS, A Bar-Or, HL Atkins, D Karussis, F Frassoni, H Lazarus, N Scolding, S Slavin, K Le Blanc, A Uccelli and MS Group. (2010). The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: Consensus report of the International MSCT Study Group. Mult Scler 16:503-510.
7. Duijvestein M, AC Vos, H Roelofs, ME Wildenberg, BB Wendrich, HW Verspaget, EM Kooy-Winkelaar, F Koning, JJ Zwaginga, et al. (2010). Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohns disease: Results of a phase I study. Gut 59:1662-1669.
8. Popp FC, B Fillenberg, E Eggenhofer, P Renner, J Dillmann, V Benseler, AA Schnitzbauer, J Hutchinson, R Deans, et al. (2011). Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation-a phase I study (MISOT-I). J Transl Med 9:124.
9. Krampera M, S Glennie, J Dyson, D Scott, R Laylor, E Simpson and F Dazzi. (2003). Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigenspecific T cells to their cognate peptide. Blood 101:3722-3729.
10. Tabera S, JA Perez-Simon, M Diez-Campelo, LI Sanchez- Abarca, B Blanco, A Lopez, A Benito, E Ocio, FM Sanchez- Guijo, C Canizo and JF San Miguel. (2008). The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica 93:1301-1309.
11. Sotiropoulou PA, SA Perez, AD Gritzapis, CN Baxevanis and M Papamichail. (2006). Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24:74-85.
12. Nasef A, N Mathieu, A Chapel, J Frick, S Francois, C Mazurier, A Boutarfa, S Bouchet, NC Gorin, D Thierry and L Fouillard. (2007). Immunosuppressive effects of mesenchymal stem cells: Involvement of HLA-G. Transplantation 84:231-237.
13. Augello A, R Tasso, SM Negrini, A Amateis, F Indiveri, R Cancedda and G Pennesi. (2005). Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 35:1482-1490.
14. Meisel R, A Zibert, M Laryea, U Gobel, W Daubener and D Dilloo. (2004). Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenasemediated tryptophan degradation. Blood 103:4619-4621.
15. Crop MJ, CC Baan, SS Korevaar, JN Ijzermans, M Pescatori, AP Stubbs, WF van Ijcken, MH Dahlke, E Eggenhofer, W Weimar and MJ Hoogduijn. (2010). Inflammatory conditions affect gene expression and function of human adipose tissue- derived mesenchymal stem cells. Clin Exp Immunol 162:474-486.
16. Krampera M, L Cosmi, R Angeli, A Pasini, F Liotta, A Andreini, V Santarlasci, B Mazzinghi, G Pizzolo, et al. (2006). Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386-398.
17. Ryan JM, F Barry, JM Murphy and BP Mahon. (2007). Interferon- gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149:353-363.
18. Barbash IM, P Chouraqui, J Baron, MS Feinberg, S Etzion, A Tessone, L Miller, E Guetta, D Zipori, et al. (2003). Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108:863-868.
19. Kraitchman DL, M Tatsumi, WD Gilson, T Ishimori, D Kedziorek, P Walczak, WP Segars, HH Chen, D Fritzges, et al. (2005). Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112:1451-1461.
20. Detante O, A Moisan, J Dimastromatteo, MJ Richard, L Riou, E Grillon, E Barbier, MD Desruet, F De Fraipont, et al. (2009). Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: In vivo imaging and biodistribution. Cell Transplant 18:1369-1379.
21. Gholamrezanezhad A, S Mirpour, M Bagheri, M Mohamadnejad, K Alimoghaddam, L Abdolahzadeh, M Saghari and R Malekzadeh. (2011). In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl Med Biol 38:961-967.
22. Chapel A, JM Bertho,M Bensidhoum, L Fouillard, RG Young, J Frick, C Demarquay, F Cuvelier, E Mathieu, et al. (2003). Mesenchymal stem cells home to injured tissues when coinfused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 5:1028-1038.
23. Jackson JS, JP Golding, C Chapon, WA Jones and KK Bhakoo. (2010). Homing of stem cells to sites of inflammatory brain injury after intracerebral and intravenous administration: A longitudinal imaging study. Stem Cell Res Ther 1:17.
24. Hoogduijn MJ, et al. (2011). Living mesenchymal stem cells disappear rapidly after intravenous infusion. Am J Transplant 11:Abstract 1413.
25. Gheisari Y, K Azadmanesh, N Ahmadbeigi, SM Nassiri, AF Golestaneh, M Naderi, M Vasei, E Arefian, S Mirab-Samiee, et al. (2012). Genetic modification of mesenchymal stem cells to overexpress CXCR4 and CXCR7 does not improve the homing and therapeutic potentials of these cells in experimental acute kidney injury. Stem Cells Dev 21:2969-2980.
26. Gonzalez MA, E Gonzalez-Rey, L Rico, D Buscher and M Delgado. (2009). Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136:978-989.
27. Zappia E, S Casazza, E Pedemonte, F Benvenuto, I Bonanni, E Gerdoni, D Giunti, A Ceravolo, F Cazzanti, et al. (2005). Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106: 1755-1761.
28. Popp FC, E Eggenhofer, P Renner, P Slowik, SA Lang, H Kaspar, EK Geissler, P Piso, HJ Schlitt and MH Dahlke. (2008). Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transplant Immunol 20:55-60.
29. Eggenhofer E, V Benseler, A Kroemer, FC Popp, EK Geissler, HJ Schlitt, CC Baan, MH Dahlke and MJ Hoogduijn. (2012). Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Alloimmun Transplant 3:297.
30. Eggenhofer E and MJ Hoogduijn. (2012). Mesenchymal stem cell-educated macrophages. Transplant Res 1:12.
31. Toma C, WR Wagner, S Bowry, A Schwartz and F Villanueva. (2009). Fate of culture-expanded mesenchymal stem cells in the microvasculature: In vivo observations of cell kinetics. Circ Res 104:398-402.
32. Hoogduijn MJ, F Popp, R Verbeek, M Masoodi, A Nicolaou, C Baan and MH Dahlke. (2010). The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. Int Immunopharmacol 10:1496-1500.
33. Lin G, M Garcia, H Ning, L Banie, YL Guo, TF Lue and CS Lin. (2008). Defining stem and progenitor cells within adipose tissue. Stem Cells Dev 17:1053-1063.
34. WexlerSA,CDonaldson,PDenning-Kendall,CRice,BBradley and JM Hows. (2003). Adult bone marrow is a rich source of human mesenchymal stem cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121:368-374.
35. Roufosse CA, NC Direkze, WR Otto and NA Wright. (2004). Circulating mesenchymal stem cells. Int J Biochem Cell Biol 36:585-597.
36. Casiraghi F, N Azzollini, P Cassis, B Imberti, M Morigi, D Cugini, RA Cavinato, M Todeschini, S Solini, et al. (2008). Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 181:3933-3946.
37. Gonzalez MA, E Gonzalez-Rey, L Rico, D Buscher and M Delgado. (2009). Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 60:1006-1019.
38. Gonzalez-Rey E, P Anderson, MA Gonzalez, L Rico, D Buscher and M Delgado. (2009). Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58:929-939.
39. Polchert D, J Sobinsky, G Douglas, M Kidd, A Moadsiri, E Reina, K Genrich, S Mehrotra, S Setty, B Smith and A Bartholomew. (2008). IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol 38:1745-1755.